Introduction: This study aimed to characterize antimicrobial resistance (AMR), molecular determinants of AMR and virulence, as well as clonal relationship of Streptococcus agalactiae isolates from women at 35-37 weeks of gestation in the Chaoshan metropolitan area of southern China. Methodology: Bacterial strains isolated from vaginal swabs were identified and antimicrobial susceptibility tests were performed by using a Vitek 2 Compact system (BioMérieux, France). Resistance and virulence genes were detected by polymerase chain reaction (PCR) and the clonal relationship was analysed by multiple locus variable number tandem repeat analysis (MLVA). Statistical analysis was carried out by using SPSS software, version 19.0. Results: All GBS were susceptible to benzylpenicillin, ampicillin, quinupristin/dalfopristin, tigecycline, linezolid and vancomycin, but a considerable proportion was resistant to clindamycin (29.67%), erythromycin (46.15%)， azithromycin (63.74%), tetracycline (84.62%) and quinolones (25.27%). The carrier rates of ermB (69.04%) and mefA/E (64.28%) were detected in these GBS strains resistant to erythromycin. In terms of MLVA detection, 91 GBS strains were categorized into 43 genotypes and 6 clusters. All GBS harboured hylB and cylE genes, most of which carried a combination of PI-1 and PI-2a genes as a common virulence gene profile. Conclusions: The high level of resistance conferred by some corresponding resistance genes to macrolides, lincosamides and quinolones of GBS isolates from pregnant women in southern China, has reinforced the necessity for monitoring GBS strain resistance to the above agents. Comparative genetic studies of GBS isolates, especially efforts to understand the relationship between pilus islands and genotype, were essential for conducting infection control and epidemiological comparisons between countries.
Introduction
Streptococcus agalactiae (group B streptococcus, GBS), a common commensal of the female genital tract, has been considered the main cause of neonatal sepsis and meningitis and as the most common agent of invasive infections in pregnant women [1] . According to the previous studies in different countries, approximately 10.00%-31.50% of pregnant women are vaginally and/or rectally colonized with GBS [2] [3] [4] [5] [6] . The universal screening for maternal GBS colonization at 35 to 37 weeks' gestation and the use of intrapartum antibiotic prophylaxis have resulted in a nearly 80% reduction in the rate of neonatal GBS infection over the past 15 years, from 1.7 cases per 1,000 live births in the early 1990s to 0.34-0.37 cases per 1,000 live births in recent years [7] . Prenatal GBS screening is recommended by the Center for Disease Control and Prevention of United States in all the pregnant women between 35 and 37 weeks of gestation [7] . In China, prenatal GBS screening is also a reference project in pregnant women.
GBS has been continuously susceptible to penicillin and other β-lactams. However, resistance to antimicrobials used as alternative therapy, especially macrolides, lincosamides and quinolones has been documented in different countries [4, 8] . Erythromycin and clindamycin are given in cases in which there is a high risk of anaphylaxis to penicillin [9] . However, increasing resistance of GBS to erythromycin and clindamycin has been reported worldwide [10] . In GBS isolates, macrolide resistance is mediated mainly by two classes of resistance genes: the mef genes and the erm genes [11] . The erm(B), erm(A) and mef(A) genes have been detected in 70.51%, 46.15% and 6.41% of 156 GBS strains in Spain, respectively [12] .
Quinolones are generally not used to treat GBS infections in pregnant women and newborns in China, but they are widely used for clinical and agricultural applications [13] . The continued widespread use of quinolones may increase the resistance of various pathogens, including S. agalactiae, to these drugs [14] . However, specific mutations found in a region of the parC and gyrA/B genes, called the quinolone resistancedetermining region (QRDR), shows result in decreased binding to and activity of quinolones and represents the main mechanism of resistance to quinolones in GBS [15] .
Pilus islands, haemolysins, and hyaluronidases played important roles in GBS adaptation and host specificity, and disease progression [16, 17] . The hyaluronidase encoded by the hylB gene promotes the spread of bacteria in host cells [16] . The product of the gene cylE is a pore-forming toxin, referred to as extracellular β-haemolysin/cytolysin (β-H/C), which is toxic to a broad range of eukaryotic cells and results in cell invasion and evasion of phagocytosis [16] . Three pilus islands (PI-1, PI-2a, and PI-2b) had been identified, which encoded different pilus structures that mediated interactions with host cell [18, 19] . Few studies, however, have characterized the distribution and genetic diversity of each PI in GBS strains from pregnant women in southern China.
Maternal and neonatal populations were those most commonly infected by GBS, and previous reports had mostly focused on the epidemiology of these special populations in other counties; however, little was known about the molecular characterization of the GBS isolates colonized in pregnant women in southern China. Therefore, this study was conducted to investigate and characterize the antimicrobial resistance, resistance genes, virulence determinants and genotypes of 91 GBS isolates collected from pregnant women in Chaoshan metropolitan area of southern China in 2015.
Methodology

Bacterial isolates
This study was conducted at the obstetrical department of a tertiary-level teaching hospital affiliated to the Shantou University Medical College (SUMC) in Shantou city in Guangdong, a populous province in southern China. The hospital (a tertiarylevel teaching hospital with 1816 inpatient beds) serves the Chaoshan metropolitan area area in eastern Guangdong. A total of 91 non-duplicated GBS isolates were systematically collected from vaginal swabs of pregnant women at 35-37 weeks of gestation during the period of January 1 st to December 31 st , 2015. These strains had previously been identified on the basis of Gram staining, colony morphology, β-haemolysis, and a positive CAMP test [20] on blood agar and were further identified by using Vitek 2 Compact system (bioMérieux, Lyon, France). Enterococcus casseliflavus (ATCC 700327) was used as the quality control strain for the GP card. Strains were stored at -80°C in the brain heart infusion broth containing 20% glycerol and 5% sheep blood.
Antimicrobial susceptibility tests
Antimicrobial susceptibility tests containing benzylpenicillin, ampicillin, clindamycin, erythromycin, levofloxacin, quinupristin/dalfopristin, tetracycline, tigecycline, linezolid, vancomycin, ciprofloxacin and moxifloxacin were obtained by using the Vitek 2 compact system with the AST-GP67 card assembly kits (BioMérieux, Lyon, France), according to the manufacturer's instructions. Antimicrobial susceptibility test (AST) results for MICs (minimum inhibitory concentrations) were interpreted according to the criteria recommended by the Clinical and Laboratory Standards Institute [21] . Staphylococcus aureus (ATCC 29213) was used as a quality control strain.
DNA extraction
Whole genomic DNA was extracted by using TIANamp Bacterial DNA Kit according to the manufacturer's instructions (Tiangen Biotech, Beijing, China).
Detection of antimicrobial resistance genes and virulence determinant genes
Detection of antimicrobial resistance genes by PCR amplification was carried out with specific primers to screen for the following genes of interest (shown in the supplementary table): macrolide resistance genes (ermB, ermTR and mefA/E), fluoroquinolone resistance genes (gyrA, gyrB and parC), and virulence determinant genes (cylE, hylB, CAMP, PI-1, PI-2a and PI-2b), as had been described in the literatures [16, 22] . Gene sequences were analysed by the Huada Genomics Company (Shen Zhen, China). The nucleotide sequences obtained were aligned with DNAMAN software. Streptococcus agalactiae strain 2603 V/R (ATCC BAA-611; GenBank accession number NC004116) was used as a reference strain for comparative analysis [22] .
Multiple-locus VNTR analysis (MLVA)
The genetic relationship between the strains was analysed by MLVA genotyping of the following six variable number tandem repeat (VNTR) alleles: SAG2, SAG3, SAG4, SAG7, SAG21, SAG22 [23] . Amplification and electrophoresis were performed as described in the literatures [23] [24] [25] . Determination of the Hamming's distance (also called the categorical coefficient) and the unweighted pair-group method with arithmetic mean (UPGMA) for cluster category were run with NTSYSpc2.10e software, which made out the minimum spanning tree (MST) [26] .
Statistical analysis
Statistical analysis on the relationship between AST and genotypes was performed by the logistic correlation method, while Spearman correlation was used to determine the relevance for antimicrobials, pilus islands and amino acid substitutions carried out with SPSS 19.0 software. Values of P ≤ 0.05 was considered to be statistically significant.
Results
Antimicrobial susceptibility
For antimicrobial susceptibility profiles, all GBS strains were susceptible to benzylpenicillin, ampicillin, quinupristin/dalfopristin, tigecycline, linezolid and vancomycin. Resistance to clindamycin, erythromycin, azithromycin and tetracycline was detected in 27, 42, 58 and 77 strains, which accounted for 29.67%, 46.15%, 63.74% and 84.62%, respectively. In addition, resistance to levofloxacin, ciprofloxacin and moxifloxacin was the same as 25.27% (Figure 1 ).
Resistance genes
As shown in Table 1 , among the 42 isolates resistant to erythromycin, 69.04% of them ( According to the mutation patterns of amino acid substitutions for quinolone antimicrobials, 23 GBS isolates which were insensitive to levofloxacin, ciprofloxacin and moxifloxacin, could be categorized into five patterns ( Table 2 ). Pattern II was the predominant mutation form ( 65.22%, 15/23), in which strains showed resistance to levofloxacin and ciprofloxacin but intermediate to moxifloxacin, with amino acid substitutions such as S81L in gyrA and S79Y in parC, respectively. Meanwhile, these two amino acid substitutions were also detected in the strains belonging to pattern I, II and IV of 20 GBS isolates (86.96%, 20/23), while the rest ones (pattern III and V) conducted the only one substitution as S79Y. Synthetically, among the 23 levofloxacin-resistant strains, all had mutations in gyrA (86.95%, 20/23) and/or parC (100%, 23/23), without any mutation in gyrB gene. The majority of isolates with mutations displayed the same types of substitutions, such as S79Y (P ≤ 0.001) and S81L (P ≤ 0.001) ( Table 3 ). However, three strains (No. 15, 18, and 40) showed resistance to levofloxacin, but no mutations were found in gyrA gene.
Detection of virulence determinants
PCR results showed that all strains carried at least one pilus island and both of hylB and cylE genes ( Figure  2 ). Nine (9.9%) of the 91 GBS strains were CAMP factor-negative. Most of strains harboured PI-2a alone (13.19%, 12/91, P ≤ 0.01), or in combination with PI-1 (42.86%, 39/91, P ≤ 0.001) ( Table 3 ). The combination of PI-1 and PI-2a was present in both cluster 1 and 3. The presence of PI-2b was uniquely observed in 32 strains (35.16%, 32/91, P ≤ 0.01) which belonged to cluster 4 to 6. Additionally, PI-1 was found in combination with PI-2b (4.40%, 4/91, P>0.05).
GBS strain origins and genotypes detected by MLVA
The clonal relationship of 91 GBS isolates was assessed by MLVA ( Figure 2 ). A total of 43 different MLVA types (MTs) were identified with a diversity index of 0.91. Six MLVA clusters were identified. The two major groups of similar MLVA profiles consisted of 25 (MT1, 27.5%) and 8 (MT42, 8.8%) isolates. In cluster 1, all isolates resistant to levofloxacin (25.27%, 23/91) belonged to the MT1 profile, and the majority of those isolates (95.56%, 22/23) harboured both PI-1 and PI-2a genes.
Discussion
The increasing emergence of resistance to macrolides among GBS isolates is a therapeutic problem among patients who are allergic to β-lactams [13] . In our study, all strains were uniformly susceptible to penicillin, consistent with a previous report [13] , indicating that penicillin remains an appropriate firstline agent option for treating GBS in genital infection for intrapartum. However, the resistance rates of erythromycin and clindamycin were 46.15% (42/91) and 29.67% (27/91), respectively. In comparison, the resistance rates of erythromycin and clindamycin in Chaoshan metropolitan area were lower than those in Beijing (85.7% and 73.2%, respectively) [14] and Shanghai (69.0% and 50.6%) [27] , similar to France (46.0% and 37.8%) [28] , but much higher than those in India (14.3% and 0.0%) [29] and Brazil (4.1% and 3.0%) [30] . Based on the observation in the high resistance to erythromycin in our study, we proposed that erythromycin should not be a priority antibiotic choice for intrapartum GBS chemoprophylaxis. Notably, The American CDC guidelines no longer recommend erythromycin as a routine antimicrobial for the treatment of GBS infection [9] . Generally, antimicrobial therapy should be guided by the antimicrobial susceptibility test and necessity for the continuous monitoring of antimicrobial susceptibility profiles should also be emphasized, as well. One of the main goals of this study was to determine the genetic basis of antimicrobial resistance. Among the 91 erythromycin-resistant strains, 42 carried one or two of three resistance genes (ermB, mefA/E, and ermTR). The high carrier rates of ermB and mefA/E implied that these two resistance genes might be the main mechanisms of GBS resistance to erythromycin. That the iMLS B isolates carried ermB and mefA/E at the same time showed consistency with the published data [16] . In our study, ermTR and iMLS B were found by statistical analysis to be correlated (P = 0.026). To our knowledge, there are no relevant previous reports similar to this finding. The high level of resistance conferred by these resistance genes reinforces the necessity for monitoring GBS strain resistance to macrolides and lincosamides.
The incidence of levofloxacin and ciprofloxacin resistance in this study was both 25.27%, which was lower than that reported in China (37.7%), but higher than that in Japan (18.4%) and the United States (4.4%) [31] . One of the mechanisms of GBS resistance to quinolones is mutations in subunits A and B of the DNA topoisomerases (gyrA, gyrB, and parC) [13, 31] . In our study, the patterns of mutations detected in the QRDR of GyrA and ParC were S81L and S79Y, respectively, without mutations in GyrB. Such finding was similar to other studies [13] , indicating that the quinoloneresistance mutations in GBS isolates were mainly due to substitutions in the parC and gyrA genes. Although, to the best of our knowledge, amino acid substitutions in GyrB have not been reported in GBS, the E476K substitution (corresponding to the E474K substitution in S. pneumoniae) may contribute to fluoroquinolone resistance [22] .
In our study, at least one type of pilus island could be detected in each GBS isolate, and most GBS isolates carried the combination of PI-1 and PI-2a genes, consistent with previous reports [32] . All GBS harboured hylB and cylE genes, most of which carried a combination of PI-1 and PI-2a genes as a common virulence gene profile. Springman [18] reported that the presence of PI-1 might increase the adaptability and colonization potential of certain strains in the human body. This pilus island allowed them to establish a niche in pregnant mothers and increase the likelihood of opportunistic infections and their subsequent spread to susceptible newborns. However, further studies and larger sample sizes are required to identify the continued colonization, invasion, and disease-related relationships of different pilus islands in GBS. Therefore, strengthening our understanding of PI distribution patterns and the genetic diversity of strains from different sources and geographic locations is crucial for future efforts to develop GBS vaccines based on pilus islands [33] .
In this study, we applied MLVA to characterize the genetic diversity of GBS isolates. This method converted our experimental results into digital alleles, which could be used to build a database for communication between laboratories. The diversity index obtained from our MLVA analysis for the bacterial population in this experiment was 0.91, which was higher than what had been reported in Brazil [16] , but lower than that in France [23] . However, despite the close relatedness of several isolates, as judged by their capsular type and presence of pilus islands, this genotyping scheme could discriminate GBS isolates [18] . In fact, a total of 43 different genetic groups had been identified, which were further divided into 6 gene clusters. Because there was a clear correlation between gene cluster and PI profile, indicating that the PI genetic background in each gene cluster might be well conserved. All of the quinolone-resistant strains were confined to MT1 in cluster 1, and the vast majority (22 out of 23 strains) carried PI-1 and PI-2a (only 1 strain carried PI-1 alone). However, the correlation between pilus islands and quinolone resistance had not been studied, and the reason why this combination was only distributed in MT1 had not been found yet. Further research on these topics is needed in the future.
Conclusions
This study revealed high resistance to macrolides, lincosamides and quinolones of GBS isolates from pregnant women in southern China, compared to some previous studies in other countries. The high level of resistance was conferred by resistance genes to macrolides, lincosamides and quinolones, which reinforced the necessity for monitoring GBS strain resistance to those agents. The genotypic characteristics showed MT1 to be a predominant MT in GBS strains from Chaoshan, which contributed to a better understanding of the epidemiology of GBS isolates. Comparative genetic studies of GBS isolates, especially efforts to understand the relationship between pilus islands and genotype, were essential for conducting infection control and epidemiological comparisons between countries.
Limitation
The low number of S. agalactiae strains obtained in this study might lead to a slight deviation in the analysis. The clinical impact of GBS infections among affected patients had not been discussed. Some data such as treatment outcomes (e.g. mortality versus discharge; birth outcomes), and hospitalization duration had not been collected and analysed to provide a measure on this regard.
